Stockreport

Altimmune, Inc. (ALT): A Bull Case Theory [Yahoo! Finance]

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors
PDF design36/Shutterstock.com Altimmune (ALT) is developing a promising drug pemvidutide for the growing obesity market. This GLP-1/glucagon dual receptor agonist will ad [Read more]